TORONTO -- A vaccine designed to prevent dementia is ready to enter the human trial stage within two years after successful tests on mice, researchers say. The study, published in the journal “Alzheimer's Research & Therapy” explores the 20 years of ...
from Google Alert - health https://ift.tt/2QG0mfo
via IFTTT
0 comments:
Post a Comment